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NigeriaBackground: The association of obesity with adiponectin gene has been reported in different populations
with various inconsistencies. Data from Nigeria is very scanty on the association.
Aim: We investigated possible associations of adiponectin gene (ADIPOQ) single nucleotide polymor-
phisms (SNPs) rs2241766 (+45T>G in exon 2), rs266729 (11377C>G in promoter) and rs1501299
(+276G>T in intron 2) with body mass index (BMI), waist circumference (WC) and hip circumference
(HC), in our cross-sectional study.
Subjects and methods: SNPs in ADIPOQ were genotyped in 107 subjects (81 females, 26 males; mean age
22.2 years) by Sequenom MassARRAY. Notably, rs2241766 was removed for not reaching
Hardy-Weinberg equilibrium. BMI was calculated (kg/m2) while WC and HC were measured using stan-
dard procedures
Results: Linear regression showed that variant rs1501299 was not associated with BMI, WC or HC but
rs266729 was associated with increased measures of obesity involving BMI (recessive model; beta
coefficient [b], 12.85; 95% confidence interval [CI], 6.47, 19.24, codominant model; GG, b, 13.08; 95%
CI, 6.71, 19.46, GC, b, 1.04; 95% CI, 0.60, 2.68 and log-additive model; b, 2.117; 95% CI, 0.55, 3.68),
WC (recessive model; b, 22.17; 95% CI, 7.11, 37.23 and codominant model; GG, b, 21.857; 95% CI, 6.74,
36.98, GC, b, 1.459; 95% CI, 5.34, 2.43) and HC (recessive model; b, 33.56; 95% CI, 15.41, 51.70, codom-
inant model; GG, b, 34.171; 95% CI, 16.04, 52.30, GC, b, 2.771; 95% CI, 1.79, 7.34 and log-additive model;
b, 5.466; 95% CI, 1.14, 9.80).
Conclusion: This study in young Nigerian adults confirmed previously reported association of SNP
11377C>G with obesity measures in other populations.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity (BMI > 30 kg/m2) is a medical condition characterised
by accumulation of excess body fats that may impair health and
is currently recognized by the world health organization (WHO)
as a chronic disease [1]. It is also a major risk factor for several
chronic diseases, including stroke, hypertension, type 2 diabetes
and different types of cancers [2–4]. Obesity is one of the leading
risk factors for global mortality and morbidity and is a growing
public health problem throughout the world [5]. In 2014, morethan 1.9 billion adults who are aged 18 years or more, were over-
weight globally and over 600 million of these adults were obese;
thus indicating that 39% and 13% of the world population are over-
weight and obese respectively [6]. Prevalence of obesity among
Nigerian adults ranges between 8.1% and 22.2% as revealed by a
meta-analysis [7].
Genetic contribution to the aetiology of obesity has been well
documented and it was reported that BMI, the WHO-adopted mea-
sure of obesity, has heritability estimate of 40–70% [8]. Although
rare monogenic forms of obesity do exist, the polygenic form is
more common, and the implicated genes thus far include,
adiponectin, adiponectin receptors 1 and 2, among others
[5,9–11]. Multiple genes (and polymorphisms within the genes)
and environmental factors such as diet and lifestyle influence
obesity but more clarification is needed to better understand the
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strongly associated with obesity and obesity-related measures by
association studies mostly in Caucasian populations [12,13].
Several independent association studies across populations
worldwide have shown that some SNPs of ADIPOQ possess obeso-
genic effects albeit with inconsistent findings, which could be as
a result of differences in ethnic populations, varying SNP selection
criteria and study power [5,14–17]. The ADIPOQ obesity-associated
variants span about 15.8 kb across three exons and are sited on
chromosome 3q27 [18]. Among these variants the rs2241766,
rs266729 and rs1501299 were studied often [14,19–21].
The ADIPOQ gene is exclusively expressed in the human adipose
tissue and codes for the adiponectin found in the plasma. Plasma
levels of adiponectin are known to be significantly decreased in
patients with obesity [22,23]. Studies have associated mutations
in ADIPOQ with human obesity cases and notably, a genome-
wide association study (GWAS) showed that the ADIPOQ gene
could account for 30–70% of the phenotypic variance for plasma
adiponectin levels [5,10,24]. Several variants of ADIPOQ have been
studied in relation to obesity, most with inconsistencies across dif-
ferent populations. Limited data on obesity risk alleles and their
association with measures of obesity such as BMI, waist and hip
circumferences exist in Nigeria. It was therefore the aim of this
study to investigate in a population sample of Nigerian young
adults the association of three previously described ADIPOQ vari-
ants with measures of obesity namely i) BMI; ii) waist circumfer-
ence and iii) hip circumference.Table 1
SNP amplification and extension primer sequences.
dbSNP rs
number
Marker Primer sequence (50 ? 30)















Extension primer GTGGTTTCCTGGTCATG2. Materials and methods
2.1. Study population
The sample cohort included healthy young adults of Nigerian
descent (n = 107), mainly from Tai Solarin University of Education
in Nigeria, being 81 females (75.7%) and 26 males (24.3%) aged
between 18 and 30 years (mean age 22.2 years). Participants were
randomly recruited from students at Tai Solarin University of Edu-
cation, Nigeria between 2016 and 2017.
2.1. Ethical approval
The study was conducted in accordance with the declaration of
Helsinki and was approved by the local institutional review com-
mittee and the Health Research Ethics Committee (HREC) of Lagos
University Teaching Hospital (LUTH) with HREC assigned number
ADM/DCST/HREC/APP/800. An informed consent was obtained
from each participant before they participated.
2.2. Anthropometry
The anthropometric measurements including weight, height,
waist and hip circumferences were obtained with individuals
wearing light cloths and no shoes following standard procedures.
Weight, height, waist and hip circumferences were taken using
weighing scale, stadiometer and measurement tape respectively.
Waist circumference was measured at the midpoint between the
lower border of the rib cage (costal margin) and the iliac crest.
Hip circumference was measured at the widest circumference over
the buttocks and below the iliac crest. BMI was calculated as
weight divided by square of height (kg/m2).
2.3. DNA Isolation and SNPs genotyping
Blood samples were obtained from participants as dried blood
spots (DBS) samples through fingerpicking. DBS samples werespotted on Whatman FTA cards (Whatman Inc., Brentford, UK)
and were dried for 24 h at room temperature according to the
method of Choi et al. [25]. They were then kept in separate clean
zipper bags and stored at room temperature until analysis. Geno-
mic deoxyribonucleic acid (DNA) was isolated from DBS samples
using Zymo Research (ZR) DNA Card Extraction Kits following
manufacturer’s protocol. SNPs were amplified by polymerase chain
reaction (PCR). PCR-specific and single-base extension primer
sequences used for SNP amplification are provided in Table 1. ADI-
POQ rs2241766, rs266729 and rs1501299 were genotyped by using
Sequenom MassARRAY Genotyping System (Sequenom, San Diego,
CA, USA) using previously described methods [26]. The genotyping
efficiency was >92%.
2.4. Statistical analysis
Hardy-Weinberg equilibrium was tested using an exact test
(HWExact) implemented in the R 3.1.3 package. Continuous data
were summarized as mean ± standard error. Statistical analyses
were performed using SNPassoc package implemented in the R
package. We applied linear regression models to test the associa-
tion of individual.
SNPs with obesity-related quantitative traits: BMI, WC and HC.
The multivariable models were adjusted for age and gender. These
regression models were implemented under four different genetic
models: a codominant model that defines the three genotypes sep-
arately, a dominant model that grouped the heterozygous with the
homozygous for the minor allele, a recessive model that grouped
the heterozygous with the homozygous for the major allele and a
log-additive model assigning a score counting the number of minor
alleles with 0, 1, and 2 given to the homozygote for the major
allele, the heterozygote, and the homozygote for the minor allele
respectively. Only the recessive, the codominant and the log-
additive models are presented in this report as these were the
models with the lowest Akaike information criteria. Bonferroni
correction of the significance values was used to correct for multi-
ple testing on multiple markers. All P values can be multiplied by 3
(the total number of SNPs used) to give Bonferroni-adjusted P val-
ues. The sample size and power of the study was calculated by
using Quanto version 1.2.4 software.3. Results
Table 2 summarises population characteristics of the studied
sample. Among the total participants (N = 107), 75.7% were
Table 2
Characteristics of the study sample and comparison between the sexes.
Variables Total Females Males P
N (%) 107 81 26
Age (years) 22.23 (2.61) 22.19 (2.69) 22.35 (2.35) 0.793
Weight (kg) 59.20 (10.76) 59.33 (11.74) 58.80 (7.06) 0.096
Height (m) 1.66 (0.08) 1.64 (0.06) 1.72 (0.08) <0.001
BMI (kg/m2) 21.63 (3.70) 22.13 (3.87) 19.80 (1.88) 0.005
WC (cm) 75.89 (8.13) 76.08 (8.89) 75.33 (5.32) 0.071
HC (cm) 93.88 (9.84) 94.63 (10.74) 91.58 (5.89) 0.063
Underweight (18.5  BMI<25 kg/m2)* 18 (16.82)
Normal (18.5  BMI<25 kg/m2)* 76 (71.03) 56 (69.14) 20 (76.92)
Overweight (25  BMI<30 kg/m2)* 9 (8.41) 8 (9.88) 1 (3.85)
Obesity (BMI  30 kg/m2)* 4 (3.74) 4 (4.94) 0 (0)
Abbreviations: N, number of individuals; BMI, body mass index; WC, waist circumference; HC, hip circumference. Data presented as mean (standard deviation) for continuous
anthropometric variables and as N (%) for categorical variables (*).
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26 male participants was 22.19 ± 2.69 years and 22.35 ± 2.35 years,
respectively. The sample included 18 underweight subjects
(16.82%), 76 normal-weight (71.03%), 9 overweight (8.41%) and 4
obese subjects (3.74%). BMI values were significantly higher in
female participants than in males. There were no significant differ-
ences in the waist circumference and hip circumference in female
participants compared with the male participants.
Genotypes and allele frequencies are detailed in Tables 3–5 for
BMI, HC and WC respectively. There was no evidence of any devi-
ation from the Hardy–Weinberg equilibrium for both ADIPOQ SNPs
rs1501299 and rs266729, but rs2241766 failed to reach Hardy-
Weinberg equilibrium and was removed from the analysis. Table 3
displays the association between ADIPOQ SNPs and BMI in three
genetic models. Minor allele frequencies were rs1501299T:0.368,
rs266729G:0.119. Statistically significant association of one vari-
ant ADIPOQ SNP rs266729 with BMI under the recessive model
(p = 0.0002), codominant model (p = 0.0004) and the log-additive
model (p = 0.0095) was found. The adjusted mean BMI (kg/m2) val-
ues for the rs266729 SNP were 20.98 ± 0.37 for participants with
the C/C genotype, 22.02 ± 0.85 for those with the C/G genotype,
and 34.06 ± 0.01 for those with the G/G genotype, and these differ-
ences were statistically significant. Although the mean BMI values
for the GG, GT and TT genotypes of ADIPOQ rs1501299 were
21.16 ± 0.66, 21.65 ± 0.52 and 21.11 ± 0.89 respectively, these dif-
ferences were not statistically significant under any of the genetic
models.
We also tested the associations between the SNPs and each of
hip circumference and waist circumference under three genetic
models. Interestingly, only SNP rs266729 showed significant asso-
ciation with hip circumference under the recessive model
(p = 0.0005), codominant model (p = 0.0011) and the log-additiveTable 3
Associations of SNPs with BMI in three genetic models.
Trait Genetic Models
SNP Chr. Genotypes M/m HWE P BMI (SE);
kg/m2
Recessive b (95%
rs1501299 3 GG:36 G/T 0.680 21.16 ± 0.66
GT:38 21.65 ± 0.52
TT:13 21.11 ± 0.89 0.296 (2.38, 1
rs266729 3 CC:68 C/G 1.000 20.98 ± 0.37
GC:19 22.02 ± 0.85
GG:1 34.06 ± 0.01 12.85 (6.47, 19.2
BMI according to genotypes. Data are means ± SE. All P values were two sided). bs and 95%
Chr., chromosome.
Bold indicates significant association.
* Indicates Bonferroni corrected values.model (p = 0.0151) – Table 4, and with waist circumference under
the recessive model (p = 0.0049) and codominant model
(p = 0.0149) – Table 5. The adjusted mean hip circumference
(cm) values for the rs266729 SNP were 91.83 ± 1.02 for partici-
pants with the C/C genotype, 94.60 ± 2.46 for those with the C/G
genotype, and 126.00 ± 0.00 for those with the G/G genotype.
These observations were significantly different under the three
genetic models. However, for rs1501299, there was no significant
difference in the mean hip circumference of participants. The waist
circumference (cm) values for the CC (75.14 ± 0.91), GC
(73.68 ± 1.76), and GG (97.00 ± 0.01) genotypes significantly dif-
fered in rs266729, but not for the GG (76.56 ± 1.40), GT
(74.83 ± 1.21) and TT (72.08 ± 2.07) genotypes in rs1501299 after
adjustment for age and gender. Minor allele frequencies were
rs1501299T:0.372, rs266729G:0.121 for HC and
rs1501299T:0.371, rs266729G:0.117 for WC.
The results from the analysis of the overall population haplo-
type block frequency for ADIPOQ rs266729 and rs1501299 revealed
that the CG haplotype (0.378) was seen frequently compared with
the CT (0.286), GG (0.070) and GT (0.013) haplotypes and signifi-
cantly associated with BMI (p < 0.001). The linkage disequilibrium
between rs266729 and rs1501299 was low (D0 = 0.619 and
R2 = 0.033).4. Discussion
The study investigated genetic changes in ADIPOQ gene in rela-
tion to obesity measures involving BMI, waist circumference and
hip circumference in a sample of young Nigerian adults and found
a significant association between these measures and rs266729







.79) 0.043 (2.30, 2.21) 0.098 (0.96, 1.15)
0.0006 0.0012 0.0285
1.04 (0.60, 2.68)
4) 13.08 (6.71, 19.46) 2.117 (0.55, 3.68)
CI were calculated using linear regression with genotypes as independent variables.
Table 4
Associations of SNPs with HC in three genetic models.
Trait Genetic Models







rs1501299 3 GG:36 G/T 0.680 92.89 ± 2.03 0.3576 0.2586 1.207 (4.15, 1.74) 0.4239
GT:41 94.10 ± 1.06 1.2089 (3.18, 5.60)
TT:13 88.92 ± 2.90 4.609 (10.35, 1.13) 3.966 (10.19, 2.26)
rs266729 3 CC:70 C/G 1.000 91.83 ± 1.02 0.0015 0.0033 5.466 (1.14, 9.80) 0.0453
GC:20 94.60 ± 2.46 2.771 (1.79, 7.34)
GG:1 126.00 ± 0.00 33.56 (15.41, 51.70) 34.171 (16.04,52.30)
HC according to genotypes. Data are means ± SE. All P values were two sided). bs and 95% CI were calculated using linear regression with genotypes as independent variables.
Chr., chromosome.
Bold indicates significant association.
* Indicates Bonferroni corrected values.
Table 5
Associations of SNPs with WC in three genetic models.
Trait Genetic Models





rs1501299 3 GG:36 G/T 0.680 76.56 ± 1.40 3.568 (8.23, 1.09) 0.4116 0.6387 2.117 (4.47, 0.24) 0.2451
GT:40 74.83 ± 1.21 1.731 (5.30, 1.84)
TT:13 72.08 ± 2.07 4.479 (9.51, 0.55)
rs266729 3 CC:70 C/G 1.000 75.14 ± 0.91 22.17 (7.11, 37.23) 0.0147 0.0447 0.9600 (2.72, 4.64) 0.6103
GC:19 73.68 ± 1.76 1.459 (5.34,2.43)
GG:1 97.00 ± 0.01 21.857 (6.74,36.98)
WC according to genotypes. Data are means ± SE. All P values were two sided). bs and 95% CI were calculated using linear regression with genotypes as independent variables.
Chr., chromosome.
Bold indicates significant association.
* Indicates Bonferroni corrected values.
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sity measures in this population.
The association of 11377G allele with a higher BMI, waist and
hip circumferences, suggests that this biomarker is possibly impli-
cated in obesity and abdominal body fat gain. Interestingly, it has
been documented that the presence of abdominal adipose tissue
may modulate the contributory effect of another SNP, rs1501299
(+276G>T) in the intronic region of the ADIPOQ gene on plasma adi-
ponectin concentrations [27]. While this study did not study adipo-
nectin concentration nor establish any significant association
between rs1501299 and obesity measures (as discussed below),
the present association study suggests that 11377G carriers of
the promoter ADIPOQ gene variant could be at greater risk of gen-
eral and regional fat increase especially among young Nigerian
population. In a similar study on two ADIPOQ promoter SNPs, Dol-
ley and colleagues [15] observed that 11391G>A polymorphism
was associated with an increased waist circumference but not
BMI. Accordingly, an inverse association between BMI and plasma
adiponectin levels has been previously reported [28], and the adi-
ponectin itself is a product of ADIPOQ gene.
The potential association between ADIPOQ rs1501299 and obe-
sity measures have been investigated in several studies [19,29–31].
Some of these studies have reported a significant association
between them [19]; however, other studies have failed to find
any associations [29–31]. We found no significant association
between ADIPOQ rs1501299 and the three measures of obesity:
BMI, waist and hip circumferences. This is in line with the findings
from several other studies including the Framingham Offspring
Study [31], the Heritage Family Study [30], the Oulu Diabetic Study
[30], and the study involving black and white women [29]. More-
over, our result is not consistent with the findings from a sample
of Egyptian young adults where significant associations werefound between ADIPOQ rs1501299 and some obesity measures
including BMI, waist to hip ratio and mid upper arm circumference
[19]. These inconsistencies in results may be explained by the dif-
ferences in the genetics or epigenetics of the respective study
populations.
It is particularly noteworthy that while the ADIPOQ polymor-
phisms involving rs2241766, rs266729 and rs1501299 were found
to be associated with obesity and obesity-related traits in several
studies in American, African, Asian and European populations, both
in children, young adults and older adults [5,14,19], other findings
on the genetic association of these SNPs with obesity parameters
have been somewhat inconsistent across different groups thus
warranting the need for replication studies across different popula-
tions, age groups or genders [5]. In this cohort, frequencies for both
the rs1501299 and the rs266729 polymorphisms, but not the
rs2241766 polymorphism were in Hardy-Weinberg equilibrium.
The frequencies of risk alleles and genotypes in ADIPOQ
rs1501299 and rs266729 slightly differed from previously reported
data in other populations [15,19,32]. This difference is expected
since there may be variability in frequencies of polymorphisms
in different populations, even within the same ethnicity [16].
Our study has some strengths and limitations. To the best of our
knowledge, this is the first Nigerian study that provides data on the
association between ADIPOQ genetic polymorphisms and obesity
measures. In terms of limitation, we did not collect data on food
and nutrient intake, physical activity, smoking and alcohol status
and some other environmental covariates that may act as modera-
tors. These variables may be considered for further studies investi-
gating gene-environment interaction. In addition, the SNPs
analyzed in the present study were not powered to detect rare
variants; there may be additional genes working in concert with
adiponectin-related genes which would need to be included to
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size. Moreover, linkage analyses involving other variants of the
ADIPOQ gene could be carried out in future studies to help to pro-
vide clearer understanding of the influence of variations at ADIPOQ
gene on obesity measures in Nigerian young adults.
Another limitation is that measurement error may occur in any
of the outcome variables or the anthropometric indices used in this
study, however, reliability was ensured as much as possible by per-
forming all measurements twice and, if the measurements differed
by more than a pre-specified value, a third measurement was
taken and the average of all three measurements used. This study
also had limited power to detect low differences between geno-
types and some of the wide confidence intervals (Cis) reported
were mostly due to the small sample size. Finally, our sample is
not nationally representative and it is uncertain if our results could
be generalized to other ethnicities.
We conclude that the GG genotype of the promoter ADIPOQ
rs266729 polymorphism was associated with each of BMI, waist
circumference and hip circumference but no association was found
between rs1501299 and the obesity measures in Nigerian young
adults. This supports current knowledge regarding the putative
influence of ADIPOQ SNPs on body corpulence. Our results should
be considered preliminary, and are likely to contain false posi-
tives/negatives, thus, replication studies of independent samples
involving different ethnic groups in Nigeria are required.
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